Affimed N.V. (AFMD), an immuno-oncology company, announced on Tuesday that Shawn Leland has been appointed as Chief Executive Officer (CEO). Andreas Harstrick, who has been acting CEO since January 2024, will continue in his role as Chief Medical Officer (CMO).
Leland brings over 15 years of experience in the pharmaceutical and biotechnology industries. Most recently, he served as Interim CEO and Board Director at ForeBio.
In July 2019, Leland founded Elevation Oncology and initially held the positions of Chief Business Officer and Board Director, before transitioning to CEO until January 2023.
Previously, Leland was Head of Business Development at Verastem Oncology from 2017 to 2019 and held a similar role at Argos Therapeutics from 2013 to 2017. He began his career at ARIAD Pharmaceuticals and Eli Lilly, where he acquired significant expertise in the sector.
